Oxysterols suppress constitutive fibrinogen expressionHUI XIA; REDMAN, Colvin M.Thrombosis and haemostasis. 2003, Vol 90, Num 1, pp 43-51, issn 0340-6245, 9 p.Article

TRANSPORT OF MELPHALAN BY SENSITIVE AND RESISTANT L1210 CELLSREDWOOD WR; COLVIN M.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 4; PP. 1144-1149; BIBL. 19 REF.Article

Crime and Social Reproduction : A Response to the Call for « Outrageous » ProposalsCOLVIN, M.Crime and Delinquency. 1991, Vol 37, Num 4, pp 436-448Article

Computer Misuse Act 1990 La loi de 1990 sur la fraude informatiqueCOLVIN, M.Computer Law and Practice. 1990, Vol 7, Num 2, pp 46-48Article

A SYMPLECTIC FIXED POINT THEOREM ON OPEN MANIFOLDSCOLVIN M; MORRISON K.1982; PROC. AM. MATH. SOC.; ISSN 0002-9939; USA; DA. 1982; VOL. 84; NO 4; PP. 601-604; BIBL. 11 REF.Article

CLINICAL PHARMACOKINETICS OF CYCLOPHOSPHAMIDEGROCHOW LB; COLVIN M.1979; CLIN. PHARMACOKINET.; NLD; DA. 1979; VOL. 4; NO 5; PP. 380-394; BIBL. 2 P.Article

ANALYSIS OF THE ANTICANCER DRUGS ETOPOSIDE (VP 16-213) AND TENIPOSIDE (VM 26) BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTIONSTRIFE RJ; JARDINE I; COLVIN M et al.1981; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1981; VOL. 224; NO 1; PP. 168-174; BIBL. 3 REF.Article

ELIMINATION OF ACUTE MYELOGENOUS LEUKEMIC CELLS FROM MARROW AND TUMOR SUSPENSIONS IN THE RAT WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDESHARKIS SJ; SANTOS GW; COLVIN M et al.1980; BLOOD; USA; DA. 1980; VOL. 55; NO 3; PP. 521-523; BIBL. 17 REF.Article

ANALYSIS OF THE ANTICANCER DRUGS VP 16-213 AND VM6 AND THEIR METABOLITES BY HIGHH-PERFORMANCE LIQUID CHROMATOGRAPHYSTRIFE RJ; JARDINE I; COLVIN M et al.1980; J. CHROMATOGR.; NLD; DA. 1980; VOL. 182; NO 2; PP. 211-220; BIBL. 15 REF.Article

NEONATAL IMPRINTING AND HEPATIC CYTACHROME P-450. II: PARTIAL PURIFICATION OF A SEX-DEPENDENT AND NEONATALLY IMPRINTED FORM(S) OF CYTOCHROME P-450CHUNG LWK; COLVIN M; CHAO H et al.1981; J. SUPRAMOL. STRUCT. CELL. BIOCHEM.; USA; DA. 1981; VOL. 15; NO 2; PP. 193-204; BIBL. 27 REF.Article

A BIOLOGICALLY ACTIVE METABOLITE OF CYCLOPHOSPHAMIDE = UN METABOLITE BIOLOGIQUEMENT ACTIF DU CYCLOPHOSPHAMIDECOLVIN M; PADGETT CA; FENSELAV C et al.1973; CANCER RES.; U.S.A.; DA. 1973; VOL. 33; NO 4; PP. 915-918; BIBL. 13 REF.Serial Issue

ELUTION OF DISPOSABLE OCTADECYLSILANE CARTRIDGES WITH HYDROPHOBIC ORGANIC SOLVENTSPALLANTE SL; STOGNLEW M; COLVIN M et al.1982; ANALYTICAL CHEMISTRY (WASHINGTON); ISSN 0003-2700; USA; DA. 1982; VOL. 54; NO 14; PP. 2612-2613; BIBL. 3 REF.Article

QUANTITATION BY GAS CHROMATOGRAPHY-CHEMICAL IONIZATION-MASS SPECTROMETRY OF PHENYLALANINE MUSTARD IN PLASMA OF PATIENTSPALLANTE SL; FENSELAU C; MENNEL RG et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 7; PP. 2268-2272; BIBL. 9 REF.Article

COMPARISON OF MUTAGENICITY, ANTITUMOR ACTIVITY, AND CHEMICAL PROPERTIES OF SELECTED NITROSOUREAS AND NITROSOAMIDESBRUNDRETT RB; COLVIN M; WHITE EH et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 4; PP. 1328-1333; BIBL. 40 REF.Article

A CHEMICAL BASIS FOR THE ANTITUMOR ACTIVITY OF CHLOROETHYLNITROSOUREASCOLVIN M; BRUNDRETT RB; COWENS W et al.1976; BIOCHEM. PHARMACOL.; G.B.; DA. 1976; VOL. 25; NO 6; PP. 695-699; BIBL. 20 REF.Article

CYCLOPHOSPHAMIDE PLASMA AND CEREBROSPINAL FLUID KINETICS WITH AND WITHOUT DIMETHYL SULFOXIDEEGORIN MJ; KAPLAN RS; SALCMAN M et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 1; PP. 122-128; BIBL. 46 REF.Article

IN VITRO EFFECTS OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE ON HUMAN IMMUNOREGULATORY T SUBSET FUNCTION. I: SELECTIVE EFFECTS ON LYMPHOCYTE FUNCTION IN T-B CELL COLLABORATIONOZER H; COWENS JW; COLVIN M et al.1982; J. EXP. MED.; ISSN 0022-1007; USA; DA. 1982; VOL. 155; NO 1; PP. 276-290; BIBL. 26 REF.Article

ALKYLATING PROPERTIES OF PHOSPHORAMIDE MUSTARDCOLVIN M; BRUNDRETT RB; KAN MNN et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 3; PP. 1121-1126; BIBL. 19 REF.Article

A Critique of Criminology: Toward an Integrated Structural-Marxist Theory of Delinquency ProductionCOLVIN, M; PAULY, J.American (The) Journal of Sociology Chicago, Ill. 1983, Vol 89, Num 3, pp 513-551Article

Onset of expression of the components of the kell blood group complexPU, Jeffrey J; REDMAN, Colvin M; VISSER, Jan W. M et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 6, pp 969-974, issn 0041-1132, 6 p.Article

Mutations that diminish expression of Kell surface protein and lead to the K_mod RBC phenotypeSOOHEE LEE; RUSSO, David C. W; REID, Marion E et al.Transfusion (Philadelphia, PA). 2003, Vol 43, Num 8, pp 1121-1125, issn 0041-1132, 5 p.Article

Point mutations causing the McLeod phenotypeRUSSO, David C. W; LEE, Soohee; REID, Marion E et al.Transfusion (Philadelphia, PA). 2002, Vol 42, Num 3, pp 287-293, issn 0041-1132Article

Neuropsychological assessment of organic solvent effects in South Africa : test selection, adaptation, scoring, and validation issuesNELL, V; MYERS, J; COLVIN, M et al.Environmental research (New York, N.Y. : Print). 1993, Vol 63, Num 2, pp 301-318, issn 0013-9351Conference Paper

validity of skin tests to cyclophosphamide and metabolitesCROMAR, B. W; COLVIN, M; CASALE, T. B et al.Journal of allergy and clinical immunology. 1991, Vol 88, Num 6, pp 965-967, issn 0091-6749Article

A real-time messaging system for Token Ring networksWEAVER, A. C; COLVIN, M. A.Software, practice & experience. 1987, Vol 17, Num 12, pp 885-897, issn 0038-0644Article